Edward Fox from the MS Clinic of Central Texas: Alemtuzumab's Long-Term Studies Show Efficacy for Multiple Sclerosis Treatment
APRIL 19, 2016
With a unique delivery method, alemtuzumab (Lemtrada) has proven to be an effective treatment option for multiple sclerosis. While careful monitoring is required, new data has shown benefits for the right patient population.
Edward J. Fox, MD, PhD, director of the MS Clinic of Central Texas, discussed the latest research on Lemtrada, which was presented at the 68th Annual Meeting of the American Academy of Neurology in Vancouver.